Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | L. Sequist, P. Cassier, A. Varga, J, Tabernero, J.Schellens, J. Delord, P. LoRusso, D. Ross Camidge, M. Hidalgo Medina, M. Schuler, M. Campone, G. Gary Tian, S. Wong, J. Corral, R. Isaacs, S.K. Sen, D. Graus Porta, S.G. Kulkarni, C. Lefebvre, J. Wolf | ||||||||||||
Title | Abstract CT326: Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors | ||||||||||||
|
|||||||||||||
URL | http://cancerres.aacrjournals.org/content/74/19_Supplement/CT326.short | ||||||||||||
Abstract Text | Cancer Res October 1, 2014 74:CT326 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|